574 related articles for article (PubMed ID: 27239419)
1. Megestrol acetate improves cardiac function in a model of cancer cachexia-induced cardiomyopathy by autophagic modulation.
Musolino V; Palus S; Tschirner A; Drescher C; Gliozzi M; Carresi C; Vitale C; Muscoli C; Doehner W; von Haehling S; Anker SD; Mollace V; Springer J
J Cachexia Sarcopenia Muscle; 2016 Dec; 7(5):555-566. PubMed ID: 27239419
[TBL] [Abstract][Full Text] [Related]
2. Rosiglitazone reduces body wasting and improves survival in a rat model of cancer cachexia.
Trobec K; Palus S; Tschirner A; von Haehling S; Doehner W; Lainscak M; Anker SD; Springer J
Nutrition; 2014 Sep; 30(9):1069-75. PubMed ID: 24976415
[TBL] [Abstract][Full Text] [Related]
3. Tandospirone reduces wasting and improves cardiac function in experimental cancer cachexia.
Elkina Y; Palus S; Tschirner A; Hartmann K; von Haehling S; Doehner W; Mayer U; Coats AJ; Beadle J; Anker SD; Springer J
Int J Cardiol; 2013 Dec; 170(2):160-6. PubMed ID: 24207070
[TBL] [Abstract][Full Text] [Related]
4. Cardiac expression of neutrophil gelatinase-associated lipocalin in a model of cancer cachexia-induced cardiomyopathy.
Musolino V; Palus S; Latouche C; Gliozzi M; Bosco F; Scarano F; Nucera S; Carresi C; Scicchitano M; von Haehling S; Jaisser F; Hasenfuss G; Anker SD; Mollace V; Springer J
ESC Heart Fail; 2019 Feb; 6(1):89-97. PubMed ID: 30367561
[TBL] [Abstract][Full Text] [Related]
5. Effects of the beta
Salazar-Degracia A; Busquets S; Argilés JM; Bargalló-Gispert N; López-Soriano FJ; Barreiro E
Biochimie; 2018 Jun; 149():79-91. PubMed ID: 29654866
[TBL] [Abstract][Full Text] [Related]
6. Simvastatin reduces wasting and improves cardiac function as well as outcome in experimental cancer cachexia.
Palus S; von Haehling S; Flach VC; Tschirner A; Doehner W; Anker SD; Springer J
Int J Cardiol; 2013 Oct; 168(4):3412-8. PubMed ID: 23680591
[TBL] [Abstract][Full Text] [Related]
7. Megestrol acetate: its impact on muscle protein metabolism supports its use in cancer cachexia.
Busquets S; Serpe R; Sirisi S; Toledo M; Coutinho J; Martínez R; Orpí M; López-Soriano FJ; Argilés JM
Clin Nutr; 2010 Dec; 29(6):733-7. PubMed ID: 20621398
[TBL] [Abstract][Full Text] [Related]
8. The small molecule ACM-001 improves cardiac function in a rat model of severe cancer cachexia.
Poetsch MS; Palus S; Van Linthout S; von Haehling S; Doehner W; Coats AJS; Anker SD; Springer J
Eur J Heart Fail; 2023 May; 25(5):673-686. PubMed ID: 36999379
[TBL] [Abstract][Full Text] [Related]
9. The xanthine oxidase inhibitor oxypurinol reduces cancer cachexia-induced cardiomyopathy.
Springer J; Tschirner A; Hartman K; von Haehling S; Anker SD; Doehner W
Int J Cardiol; 2013 Oct; 168(4):3527-31. PubMed ID: 23751350
[TBL] [Abstract][Full Text] [Related]
10. Erythropoietin improves cardiac wasting and outcomes in a rat model of liver cancer cachexia.
Saitoh M; Hatanaka M; Konishi M; Ishida J; Palus S; Ebner N; Döhner W; von Haehling S; Anker SD; Springer J
Int J Cardiol; 2016 Sep; 218():312-317. PubMed ID: 27240157
[TBL] [Abstract][Full Text] [Related]
11. Nutritional leucine supplementation attenuates cardiac failure in tumour-bearing cachectic animals.
Toneto AT; Ferreira Ramos LA; Salomão EM; Tomasin R; Aereas MA; Gomes-Marcondes MC
J Cachexia Sarcopenia Muscle; 2016 Dec; 7(5):577-586. PubMed ID: 27030817
[TBL] [Abstract][Full Text] [Related]
12. Megestrol acetate for the treatment of anorexia-cachexia syndrome.
Berenstein EG; Ortiz Z
Cochrane Database Syst Rev; 2005 Apr; (2):CD004310. PubMed ID: 15846706
[TBL] [Abstract][Full Text] [Related]
13. Prospective randomised trial of two dose levels of megestrol acetate in the management of anorexia-cachexia syndrome in patients with metastatic cancer.
Gebbia V; Testa A; Gebbia N
Br J Cancer; 1996 Jun; 73(12):1576-80. PubMed ID: 8664133
[TBL] [Abstract][Full Text] [Related]
14. Randomized double-blind clinical trial of combined treatment with megestrol acetate plus celecoxib versus megestrol acetate alone in cachexia-anorexia syndrome induced by GI cancers.
Kouchaki B; Janbabai G; Alipour A; Ala S; Borhani S; Salehifar E
Support Care Cancer; 2018 Jul; 26(7):2479-2489. PubMed ID: 29442239
[TBL] [Abstract][Full Text] [Related]
15. Effect of the specific proteasome inhibitor bortezomib on cancer-related muscle wasting.
Penna F; Bonetto A; Aversa Z; Minero VG; Rossi Fanelli F; Costelli P; Muscaritoli M
J Cachexia Sarcopenia Muscle; 2016 Jun; 7(3):345-54. PubMed ID: 27239411
[TBL] [Abstract][Full Text] [Related]
16. Prevention of liver cancer cachexia-induced cardiac wasting and heart failure.
Springer J; Tschirner A; Haghikia A; von Haehling S; Lal H; Grzesiak A; Kaschina E; Palus S; Pötsch M; von Websky K; Hocher B; Latouche C; Jaisser F; Morawietz L; Coats AJ; Beadle J; Argiles JM; Thum T; Földes G; Doehner W; Hilfiker-Kleiner D; Force T; Anker SD
Eur Heart J; 2014 Apr; 35(14):932-41. PubMed ID: 23990596
[TBL] [Abstract][Full Text] [Related]
17. Megestrol acetate in patients with AIDS and cachexia.
Oster MH; Enders SR; Samuels SJ; Cone LA; Hooton TM; Browder HP; Flynn NM
Ann Intern Med; 1994 Sep; 121(6):400-8. PubMed ID: 8053613
[TBL] [Abstract][Full Text] [Related]
18. Effect of megestrol acetate on weight loss induced by tumour necrosis factor alpha and a cachexia-inducing tumour (MAC16) in NMRI mice.
Beck SA; Tisdale MJ
Br J Cancer; 1990 Sep; 62(3):420-4. PubMed ID: 2206950
[TBL] [Abstract][Full Text] [Related]
19. [Croatian guidelines for use of eicosapentaenoic acid and megestrol acetate in cancer cachexia syndrome].
Krznarić Z; Juretić A; Samija M; Dintinjana RD; Vrdoljak E; Samarzija M; Kolacek S; Vrbanec D; Prgomet D; Ivkić M; Zelić M;
Lijec Vjesn; 2007 Dec; 129(12):381-6. PubMed ID: 18383739
[TBL] [Abstract][Full Text] [Related]
20. Differential structural features in soleus and gastrocnemius of carnitine-treated cancer cachectic rats.
Busquets S; Pérez-Peiró M; Salazar-Degracia A; Argilés JM; Serpe R; Rojano-Toimil A; López-Soriano FJ; Barreiro E
J Cell Physiol; 2020 Jan; 235(1):526-537. PubMed ID: 31241186
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
